Upcoming Webinar

This webinar has ended.

If you were unable to attend or simply want to revisit the content, the recording of the information will be available for the next 90 days.* 

Watch now

*It will take 2-3 business days after the webinar broadcasts for the recording to be uploaded.

More webinars coming soon. Register today ->

“Elevating Benign Gynecologic Surgery: Insights From Two da Vinci Surgeons”

Thursday, February 27, 2025    
5 p.m. PT / 8 p.m. ET
Marriott Conference Center San Diego
Register now

We invite you to register for the upcoming Gynecology Channel webinar, “Elevating Benign Gynecologic Surgery: Insights From Two da Vinci Surgeons.” Hear from Drs. Quanita Crable and Shanti Mohling on the value of Total Practice* with da Vinci. Join us on February 27 to explore:

  • Surgeon autonomy and efficiency
  • Review of clinical post-operative outcomes
  • Video review of endometriosis resection and hysterectomy with da Vinci
  • Advanced technology
  • Unified ecosystem resources
  • Intuitive’s digital portfolio
We hope you’ll be able to attend.

Presented by

Speaker 1

Quanita Crable, MD

Texas Health Presbyterian Hospital, Dallas
Speaker 2

Shanti Mohling, MD

Legacy Good Samaritan Medical Center, Portland, OR
Speaker 3

Speaker 4

Speaker 5

Speaker 6

Broadcast from
Download brochure

Register

Intro goes here


*Total da Vinci practice refers to the transferable value of robotic-assisted surgery with a da Vinci system across procedures in a surgeon's minimally invasive practice. It is at the surgeon's discretion to determine when a patient is a candidate for minimally invasive surgery and whether robotic-assisted surgery with a da Vinci system is an option.

†SurgeOn is a third-party app that is not sponsored by Intuitive.

Financial disclosure

The physicians have received compensation from Intuitive for consulting and/or educational services.

HCP opinion disclosure

Intuitive is sponsoring this presentation. The surgeons are presenting at the request of Intuitive and have received compensation from Intuitive for consulting and/or educational services. The views and opinions expressed are the surgeons alone and do not necessarily reflect the official policy or position of Intuitive. The information being presented is consistent with U.S. Food and Drug Administration guidelines, and other regulatory agencies around the world, and is not intended to promote the off-label use of the discussed product(s). All content is created and published for informational purposes only. It is not meant to offer medical, legal, accounting, regulatory compliance, or reimbursement advice and is not intended to establish a standard of care. Please consult professionals in these areas if you have related questions or concerns.


Indications for use / intended use

The Intuitive Surgical Endoscopic Instrument Control System (da Vinci 5 Surgical System) shall assist in the accurate control of Intuitive Surgical Endoscopic Instruments including rigid endoscopes, blunt and sharp endoscopic dissectors, scissors, scalpels, forceps/pick-ups, needle holders, endoscopic retractors, electrocautery and accessories for endoscopic manipulation of tissue, including grasping, cutting, blunt and sharp dissection, approximation, ligation, electrocautery, suturing, and delivery and placement of microwave and cryogenic ablation probes and accessories, during urologic surgical procedures, general laparoscopic surgical procedures, gynecologic laparoscopic surgical procedures and general thoracoscopic surgical procedures. The system is indicated for adult use.

It is intended to be used by trained physicians in an operating room environment in accordance with the representative, specific procedures set forth in the Professional Instructions for Use.


Contraindication

Use of the force feedback needle driver is contraindicated in hysterectomy and myomectomy due to the risk of vaginal bleeding requiring hospital readmission and/or the need for additional procedures. The use of non-force feedback needle drivers is recommended for suturing in these procedures.


Precaution for representative uses

The demonstration of safety and effectiveness for the representative-specific procedures was based on evaluation of the device as a surgical tool and did not include evaluation of outcomes related to the treatment of cancer (overall survival, disease-free survival, local recurrence) or treatment of the patient’s underlying disease or condition. Device usage in all surgical procedures should be guided by the clinical judgment of an adequately trained surgeon.

For risks, cautions, and warnings and full prescribing information, refer to the associated user manual(s).

This site uses cookies for personalization, measuring site traffic, and providing an optimal user experience. Click 'Accept' to opt into this enhanced experience or 'Reject' to reject all cookies except essential cookies required for the website to function.